HealthFinancial Postabout 4 hours ago
Alpha Cognition Reports Positive BEACON Study Results for ZUNVEYL
1 min read
Alpha Cognition announced top-line results from the BEACON real-world study of ZUNVEYL in Alzheimer's disease. Providers reported cognitive improvement in 92% of patients, neuropsychiatric symptom improvement in 93%, and favorable gastrointestinal tolerability. The study evaluated long-term care residents with mild to moderate Alzheimer's disease.
Level
Hype check
Tap to vote and see what everyone thinks.
